Fortress Biotech, Inc.
FBIO
$2.76
$0.072.60%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -62.22% | 246.32% | -56.45% | 47.42% | -17.53% |
| Total Depreciation and Amortization | 0.09% | -2.94% | 5.87% | 17.55% | -19.65% |
| Total Amortization of Deferred Charges | -29.27% | 52.88% | -1.67% | -22.88% | -48.54% |
| Total Other Non-Cash Items | 76.49% | -406.01% | -308.12% | 38.08% | 71.39% |
| Change in Net Operating Assets | 33.12% | -127.45% | 48.02% | -2.82% | -124.57% |
| Cash from Operations | 77.83% | -40.88% | -51.57% | 35.65% | 8.15% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -52.84% | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -52.84% | 422.40% | 107.77% | -- | -- |
| Total Debt Issued | -- | -- | -- | -85.14% | 573.36% |
| Total Debt Repaid | -- | 100.00% | 0.00% | 0.00% | -- |
| Issuance of Common Stock | 191.91% | -45.07% | 66.91% | -91.63% | 246.62% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | 100.00% | 23.33% | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | 100.00% |
| Other Financing Activities | 233.45% | -92.24% | 149.54% | 154.07% | -528.87% |
| Cash from Financing | 233.38% | -91.33% | 102.05% | 851.90% | -81.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 169.79% | -150.24% | 1,706.09% | 87.89% | -129.08% |